Business · 14/12/2001Updated: 10/17/2026 · 1 min read
FDA Announces Collection of Information for Prescription Drug Product Labeling; Requests Public Comment
Summary
The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to prescription drug product labeling and medication guide requirements, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →